Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00644163 · ClinicalTrials.gov registry record · NA
Effectiveness of a Risk Reduction Program in Preventing the Transmission of HIV and Sexually Transmitted Diseases in African-American Couples
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 1,070
- Enrollment target
NCT00644163: Completed NA study, sponsored by University of Pennsylvania.
NCT00644163 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 1,070 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (24% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00644163, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,070 participants
- Enrollment target
Study Summary
This study will evaluate the effectiveness of a risk-reduction program in preventing the transmission of HIV and sexually transmitted diseases among African-American heterosexual couples, with one partner having been previously diagnosed with an HIV infection.
Interventions
- BEHAVIORAL Eban HIV/STD Risk Reduction Intervention
- BEHAVIORAL Eban Health Promotion Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,070 participants |
| Start Date | 2003-11 |
| Est. Completion | 2007-06 |
| Phase | NA |
What the finished NCT00644163 record still lists
NCT00644163 is an interventional study that assigns participants to a tested intervention. Its 1,070 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (24% lower).
The record links to 0 conditions, and to 2 interventions - of which Eban HIV/STD Risk Reduction Intervention is the first listed.
NCT00644163 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00644163 about?
NCT00644163 is a clinical study titled "Effectiveness of a Risk Reduction Program in Preventing the Transmission of HIV and Sexually Transmitted Diseases in African-American Couples". This study will evaluate the effectiveness of a risk-reduction program in preventing the transmission of HIV and sexually transmitted diseases among African-American heterosexual couples, with one partner having been previously diagnosed with an HIV infection.
What is the current status of trial NCT00644163?
This trial is currently completed. It is a NA study. The enrollment target is 1,070 participants. The study started on 2003-11. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00644163?
The interventions under investigation include: Eban HIV/STD Risk Reduction Intervention (BEHAVIORAL), Eban Health Promotion Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00644163?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00644163's enrollment target sits among peer trials
1,070 97th of 2000 higher than 1,904 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06751043 · 1,072 participants · NA
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
- NCT06159673 · 1,074 participants · Phase 2
ACP-204 in Adults With Alzheimer's Disease Psychosis
- NCT06658808 · 1,075 participants · NA
Efficacy-Implementation Study for PC CARES in Rural Alaska
- NCT04165798 · 1,065 participants
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia